Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 18.874
Filtrer
1.
Br J Surg ; 111(6)2024 Jun 12.
Article de Anglais | MEDLINE | ID: mdl-38916133

RÉSUMÉ

Surgical technique is essential to ensure safe minimally invasive adrenalectomy. Due to the relative rarity of adrenal surgery, it is challenging to ensure adequate exposure in surgical training. Surgical video analysis supports auto-evaluation, expert assessment and could be a target for automatization. The developed ontology was validated by a European expert consensus and is applicable across the surgical techniques encountered in all participating centres, with an exemplary demonstration in bi-centric recordings. Standardization of adrenalectomy video analysis may foster surgical training and enable machine learning training for automated safety alerts.


Sujet(s)
Surrénalectomie , Méthode Delphi , Laparoscopie , Apprentissage machine , Humains , Surrénalectomie/enseignement et éducation , Surrénalectomie/méthodes , Laparoscopie/enseignement et éducation , Laparoscopie/méthodes , Projets pilotes , Enregistrement sur magnétoscope
2.
Rev Med Suisse ; 20(878): 1163-1166, 2024 Jun 12.
Article de Français | MEDLINE | ID: mdl-38867561

RÉSUMÉ

Primary aldosteronism is the most common cause of secondary hypertension in the middle-aged population. A high level of suspicion is required, due to the higher morbidity and mortality associated with damage to target organs (heart, brain, vessels, kidneys) than with essential hypertension. Screening involves 3 phases: detection, confirmation and detection of lateralization if surgery is an option. The choice of treatment will depend on the cause and the patient's wishes and may be either medical (mineralocorticoid receptor antagonists) or surgical (unilateral adrenalectomy). Both treatment options reduce the risk of cardiovascular morbidity and mortality if blood pressure is well controlled.


L'hyperaldostéronisme primaire est la cause la plus fréquente d'hypertension artérielle secondaire dans la population d'âge moyen. Un haut niveau de suspicion doit être de mise en raison d'une morbimortalité liée aux atteintes d'organes cibles (cœur, cerveau, vaisseaux, reins) plus élevée que lors d'hypertension artérielle essentielle. Le dépistage se fait en 3 phases : détection, confirmation et recherche de latéralisation si une chirurgie est envisageable. Le choix du traitement va dépendre de la cause et des désirs du patient et peut être médicamenteux (antagonistes des récepteurs des minéralocorticoïdes) ou chirurgical (surrénalectomie unilatérale). Les deux options thérapeutiques diminuent le risque de morbimortalité cardiovasculaire si la tension artérielle est bien contrôlée.


Sujet(s)
Surrénalectomie , Hyperaldostéronisme , Hypertension artérielle , Antagonistes des récepteurs des minéralocorticoïdes , Humains , Hyperaldostéronisme/chirurgie , Hyperaldostéronisme/diagnostic , Hyperaldostéronisme/complications , Surrénalectomie/méthodes , Hypertension artérielle/diagnostic , Antagonistes des récepteurs des minéralocorticoïdes/usage thérapeutique , Adulte d'âge moyen
3.
BMJ Case Rep ; 17(6)2024 Jun 11.
Article de Anglais | MEDLINE | ID: mdl-38862185

RÉSUMÉ

The following case discusses the surgical considerations for a patient presenting with cardiogenic shock secondary to a phaeochromocytoma crisis with stress cardiomyopathy. The patient underwent an interval laparoscopic adrenalectomy. Pneumoperitoneum insufflation was performed at lower pressures; manipulation of the adrenal tumour was minimised, and the adrenal vein was ligated early. However, as intraoperative blood pressure (BP) remained elevated and rising, further gentle dissection revealed an aberrant inferior phrenic vein draining the adrenal nodule. BP was finally reduced following ligation of the inferior phrenic vein, demonstrating the clinical significance of an unusual dual venous drainage from the adrenal nodule in this patient.


Sujet(s)
Tumeurs de la surrénale , Surrénalectomie , Phéochromocytome , Humains , Phéochromocytome/chirurgie , Phéochromocytome/complications , Tumeurs de la surrénale/chirurgie , Tumeurs de la surrénale/complications , Surrénalectomie/méthodes , Syndrome de tako-tsubo , Femelle , Choc cardiogénique/étiologie , Adulte d'âge moyen , Laparoscopie/méthodes , Soins périopératoires/méthodes , Mâle
7.
Pan Afr Med J ; 47: 88, 2024.
Article de Français | MEDLINE | ID: mdl-38737225

RÉSUMÉ

Ectopic ACTH-secreting pheochromocytoma is a very rare cause of Cushing´s syndrome, posing diagnostic and therapeutic challenges. We here report the case of a female patient with suspected severe Cushing´s syndrome associated with melanoderma, arterial hypertension resistant to triple therapy and unbalanced diabetes treated with insulin therapy. Biologically, urinary ethoxylated, 24-hour urinary free cortisol and ACTH were very high. Imaging showed a 3.5 cm left adrenal mass. The patient underwent left adrenalectomy after medical preparation, with good clinico-biological outcome. Anatomopathological examination confirmed the diagnosis of pheochromocytoma. This case study highlights the importance of measuring methoxylated derivatives in any patient with ACTH-dependent Cushing´s syndrome associated with an adrenal mass. The aim is to ensure early treatment and avoid life-threatening complications.


Sujet(s)
Tumeurs de la surrénale , Hormone corticotrope , Phéochromocytome , Adulte , Femelle , Humains , Adulte d'âge moyen , Tumeurs de la surrénale/diagnostic , Tumeurs de la surrénale/métabolisme , Tumeurs de la surrénale/complications , Surrénalectomie/méthodes , Hormone corticotrope/métabolisme , Syndrome de Cushing/étiologie , Syndrome de Cushing/diagnostic , Hydrocortisone/métabolisme , Hypertension artérielle/étiologie , Phéochromocytome/diagnostic , Phéochromocytome/métabolisme , Phéochromocytome/complications
9.
Front Endocrinol (Lausanne) ; 15: 1369582, 2024.
Article de Anglais | MEDLINE | ID: mdl-38745957

RÉSUMÉ

Context: The prevalence of unilateral primary aldosteronism (UPA) with cortisol co-secretion varies geographically. Objective: To investigate the prevalence and clinical characteristics of UPA with cortisol co-secretion in a Chinese population. Design: Retrospective cohort study. Methods: We recruited 580 patients with UPA who underwent cosyntropin stimulation test (CST) after the 1-mg dexamethasone suppression test (DST) and retrospectively analyzed the clinical characteristics and postoperative outcomes of UPA with and without cortisol co-secretion. Results: UPA with cortisol co-secretion (1 mg DST>1.8 ug/dL) was identified in 65 of 580 (11.2%) patients. These patients were characterized by older age, longer duration of hypertension, higher concentration of plasma aldosterone and midnight cortisol, lower adrenocorticotropic hormone (ACTH) and dehydroepiandrosterone sulfate (DHEAS), larger tumor diameter, and more history of diabetes mellitus. Cortisol and aldosterone levels were higher and DHEAS level was lower in UPA with cortisol co-secretion at 0-120 min after CST. Among 342 UPA patients with KCNJ5 gene sequencing and follow-up results, the complete clinical success rate was lower in UPA with cortisol co-secretion (33.3% vs. 56.4%, P<0.05); the complete biochemical success rate and KCNJ5 mutation did not differ between the two groups. Age, tumor size, and ACTH were independent predictors of UPA with cortisol co-secretion. Sex, BMI, duration of hypertension, KCNJ5 mutation, and cortisol co-secretion were independent predictors for complete clinical success in UPA after surgery. Conclusions: UPA with cortisol co-secretion is not uncommon in China, but the clinical features were distinctly different from those without co-secretion. Cortisol co-secretion is an independent risk factor for incomplete clinical success after surgery in UPA.


Sujet(s)
Hydrocortisone , Hyperaldostéronisme , Humains , Hyperaldostéronisme/chirurgie , Hyperaldostéronisme/métabolisme , Hyperaldostéronisme/sang , Mâle , Femelle , Adulte d'âge moyen , Hydrocortisone/sang , Études rétrospectives , Adulte , Aldostérone/sang , Surrénalectomie , Chine/épidémiologie , Résultat thérapeutique , Hormone corticotrope/sang , Canaux potassiques rectifiants entrants couplés aux protéines G/génétique , Canaux potassiques rectifiants entrants couplés aux protéines G/métabolisme , Études de suivi , Pronostic
10.
BMC Cardiovasc Disord ; 24(1): 261, 2024 May 20.
Article de Anglais | MEDLINE | ID: mdl-38769478

RÉSUMÉ

BACKGROUND: Pheochromocytoma is rare in pregnant women. It presents as diverse symptoms, including hypertension and sweating. The symptoms of pregnant women with pheochromocytoma and comorbid hypertension often mimic the clinical manifestations of preeclampsia, and these women are often misdiagnosed with preeclampsia. CASE PRESENTATION: In this case, a pregnant woman presented with chest pain as the primary symptom, and a diagnosis of pheochromocytoma was considered after ruling out myocardial ischemia and aortic dissection with the relevant diagnostic tools. This patient then underwent successful surgical resection using a nontraditional management approach, which resulted in a positive clinical outcome. CONCLUSIONS: It is essential to consider pheochromocytoma as a potential cause of chest pain and myocardial infarction-like electrocardiographic changes in pregnant women, even if they do not have a history of hypertension.


Sujet(s)
Tumeurs de la surrénale , Phéochromocytome , Complications tumorales de la grossesse , Humains , Phéochromocytome/complications , Phéochromocytome/diagnostic , Phéochromocytome/chirurgie , Femelle , Grossesse , Tumeurs de la surrénale/complications , Tumeurs de la surrénale/chirurgie , Tumeurs de la surrénale/diagnostic , Complications tumorales de la grossesse/diagnostic , Complications tumorales de la grossesse/chirurgie , Adulte , Résultat thérapeutique , Douleur thoracique/étiologie , Douleur thoracique/diagnostic , Valeur prédictive des tests , Surrénalectomie , Électrocardiographie
11.
Sci Rep ; 14(1): 12174, 2024 05 28.
Article de Anglais | MEDLINE | ID: mdl-38806567

RÉSUMÉ

Robotic adrenalectomy (RA) has gained significant popularity in the management of adrenal gland diseases. We report our experience at a single tertiary institution and evaluate the safety and surgical outcomes of RA. The data of 122 consecutive patients who underwent RA from October 2009 to December 2022 at Korea University Anam Hospital (Seoul, Korea) were reviewed. There were no perioperative complications. Clinicopathological features and surgical outcomes were retrospectively analyzed through complete chart reviews. Noteworthy findings include the influence of sex, tumor size, and body mass index on operation time, with the female and small tumor groups exhibiting shorter operation times (P = 0.018 and P = 0.009, respectively). Pheochromocytoma was identified as a significant independent risk factor for a longer operation time in the multivariate analysis [odds ratio (OR), 3.709; 95% confidence interval (CI), 1.127-12.205; P = 0.031]. A temporal analysis revealed a decreasing trend in mean operation times across consecutive groups, reflecting a learning curve associated with RA adoption. RA is a safe and effective operative technique alternative to laparoscopic adrenalectomy that has favorable surgical outcomes and enhances the convenience of the operation.


Sujet(s)
Tumeurs de la surrénale , Surrénalectomie , Durée opératoire , Interventions chirurgicales robotisées , Humains , Femelle , Surrénalectomie/méthodes , Surrénalectomie/effets indésirables , Mâle , Interventions chirurgicales robotisées/méthodes , Interventions chirurgicales robotisées/effets indésirables , Adulte d'âge moyen , Études rétrospectives , Résultat thérapeutique , Adulte , Tumeurs de la surrénale/chirurgie , Tumeurs de la surrénale/anatomopathologie , Sujet âgé , Phéochromocytome/chirurgie , Phéochromocytome/anatomopathologie , Facteurs de risque , Complications postopératoires/épidémiologie , Complications postopératoires/étiologie , Laparoscopie/méthodes , Laparoscopie/effets indésirables
12.
Front Endocrinol (Lausanne) ; 15: 1374711, 2024.
Article de Anglais | MEDLINE | ID: mdl-38808111

RÉSUMÉ

Objective: This systematic review and meta-analysis was conducted to compare the benefits of adrenalectomy and conservative treatment for comorbidities associated with mild autonomous cortisol secretion (MACS) in patients diagnosed with MACS. Background: MACS is the most common benign hormone-secreting functional adrenal incidentaloma. Overproduction of cortisol is observed in MACS patients, resulting in a variety of long-term health issues, including arterial hypertension (HTN), diabetes mellitus (DM), dyslipidemia, obesity, and osteoporosis; however, the classic clinical manifestations of Cushing's syndrome (CS) are not present. Methods: A systematic search was conducted using MEDLINE, Embase, Web of Sciences, and Scopus databases on December, 2023. Two reviewers independently extracted data and assessed the quality of the included articles. A meta-analysis was performed to compare the beneficial effects of adrenalectomy versus conservative management for MACS-related comorbidities. Results: Fifteen articles were included in this study, which evaluated 933 MACS patients (384 Adrenalectomy and 501 Conservative treatment, and 48 excluded due to incomplete follow-up duration). MACS diagnosis criteria were different among the included articles. All studies, however, stated that there must be no overt CS symptoms. Meta-analysis demonstrates the overall advantage of adrenalectomy over conservative treatment for MACS-related comorbidities (Cohen's d = -0.49, 95% CI [-0.64, -0.34], p = 0.00). Subgroup analysis indicated that the systolic blood pressure (pooled effect size = -0.81, 95% CI [-1.19, -0.42], p = 0.03), diastolic blood pressure (pooled effect size = -0.63, 95% CI [-1.05, -0.21], p = 0.01), and BMD (pooled effect size = -0.40, 95% CI [-0.73, -0.07], p = 0.02) were significantly in favor of adrenalectomy group rather than conservative treatment but no significant differences between the two treatment groups in other MACS-related comorbidities were reported. Conclusion: Despite the limited and diverse data, this study demonstrates the advantage of adrenalectomy over conservative treatment for MACS-related comorbidities.


Sujet(s)
Tumeurs de la surrénale , Surrénalectomie , Traitement conservateur , Hydrocortisone , Humains , Hydrocortisone/métabolisme , Hydrocortisone/sang , Tumeurs de la surrénale/chirurgie , Tumeurs de la surrénale/métabolisme , Tumeurs de la surrénale/thérapie , Traitement conservateur/méthodes , Syndrome de Cushing/chirurgie , Syndrome de Cushing/métabolisme , Syndrome de Cushing/thérapie , Hypertension artérielle/épidémiologie
13.
J Med Case Rep ; 18(1): 258, 2024 May 24.
Article de Anglais | MEDLINE | ID: mdl-38783354

RÉSUMÉ

BACKGROUND: Angiosarcoma of the adrenal gland is a very rare malignant vascular neoplasm. The clinical symptoms are atypical or completely absent. Angiosarcomas of the adrenal gland are therefore often discovered incidentally, and the diagnosis is made histologically after resection. CASE PRESENTATION: A 46-year-old white Spanish male who was a previous smoker and nondrinker and was slightly overweight (92 kg, 176 cm, body mass index 29.7 kg/m2) with no relevant medical history presented to the internal medicine emergency department of our hospital with an unclear 12 cm tumor of the right adrenal gland. Prior to the computed tomography scan, he had had persistent evening fevers for 4 months and unintentional weight loss of 5 kg. The laboratory results showed anemia and an elevated C-reactive protein, but no hormone production. We performed an open adrenalectomy of the right adrenal gland. Finally, the histologic findings revealed an angiosarcoma of the adrenal gland. CONCLUSION: Even though angiosarcomas of the adrenal gland are rare, the differential diagnosis of an angiosarcoma should be considered if a malignant tumor of the adrenal gland is suspected. Treatment decisions should be made on an interdisciplinary basis and preferably in a specialized center. Owing to the rarity of angiosarcomas of the adrenal gland, it is necessary to continue to share clinical experience to gain a better understanding of this particular tumor entity.


Sujet(s)
Tumeurs de la surrénale , Surrénalectomie , Fièvre , Hémangiosarcome , Humains , Mâle , Hémangiosarcome/diagnostic , Hémangiosarcome/chirurgie , Hémangiosarcome/anatomopathologie , Adulte d'âge moyen , Tumeurs de la surrénale/chirurgie , Tumeurs de la surrénale/diagnostic , Tumeurs de la surrénale/anatomopathologie , Fièvre/étiologie , Diagnostic différentiel , Tomodensitométrie , Récidive
14.
Sci Rep ; 14(1): 11209, 2024 05 16.
Article de Anglais | MEDLINE | ID: mdl-38755394

RÉSUMÉ

Adrenal gland incidentaloma is frequently identified through computed tomography and poses a common clinical challenge. Only selected cases require surgical intervention. The primary aim of this study was to compare the effectiveness of selected machine learning (ML) techniques in proper qualifying patients for adrenalectomy and to identify the most accurate algorithm, providing a valuable tool for doctors to simplify their therapeutic decisions. The secondary aim was to assess the significance of attributes for classification accuracy. In total, clinical data were collected from 33 patients who underwent adrenalectomy. Histopathological assessments confirmed the proper selection of 21 patients for surgical intervention according to the guidelines, with accuracy reaching 64%. Statistical analysis showed that Supported Vector Machines (linear) were significantly better than the baseline (p < 0.05), with accuracy reaching 91%, and imaging features of the tumour were found to be the most crucial attributes. In summarise, ML methods may be helpful in qualifying patients for adrenalectomy.


Sujet(s)
Tumeurs de la surrénale , Surrénalectomie , Apprentissage machine , Humains , Tumeurs de la surrénale/chirurgie , Tumeurs de la surrénale/anatomopathologie , Tumeurs de la surrénale/imagerie diagnostique , Mâle , Surrénalectomie/méthodes , Femelle , Adulte d'âge moyen , Sujet âgé , Tomodensitométrie , Adulte , Algorithmes
15.
Surgery ; 176(1): 76-81, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38594100

RÉSUMÉ

BACKGROUND: Although uncommon, adrenal hemorrhage has multiple etiologies. Because clinical characteristics, management, and outcomes of patients with adrenal hemorrhage are inadequately described, we examined the underlying etiology, need for intervention, evolution of imaging characteristics, and adequacy of subsequent evaluation. METHODS: We performed a retrospective review of patients diagnosed with adrenal hemorrhage (radiologist-confirmed density consistent with hemorrhage on computed tomography) from 2005 to 2021 at a university-based institution. Demographic characteristics, hemorrhage etiology, and subsequent follow-up were analyzed. RESULTS: Of 193 adrenal hemorrhage patients, the mean age was 49.2 ± 18.3 years, and 35% were female. Clinical presentations included trauma (47%), abdominal or flank pain (28%), incidental findings on imaging acquired for other reasons (12%), postoperative complication (8%), or shock (3%). Hemorrhage outside of the gland was present in 62% of patients. Unilateral hemorrhage was more frequent (93%) than bilateral (7%). A total of 12% of patients had nodules, but only 70% of these were identified on initial imaging, and only 43% had hormonal evaluation. Of 7 patients who had adrenalectomy or biopsy, pathology was either benign (57%) or nonadrenal malignancy (43%). No adrenocortical carcinomas were identified. Follow-up imaging was performed in 56% of patients and revealed decreased, stable, resolved, or increased adrenal hemorrhage size in 39%, 19%, 30%, and 12% of patients, respectively. CONCLUSION: Adrenal hemorrhage is secondary to multiple etiologies, most commonly trauma. In the setting of adrenal hemorrhage, many adrenal nodules were not identified on initial imaging. Only a minority of patients with nodules underwent "complete" biochemical evaluation. Follow-up imaging may improve the identification of underlying nodules needing hormonal evaluation.


Sujet(s)
Maladies des surrénales , Hémorragie , Tomodensitométrie , Humains , Femelle , Adulte d'âge moyen , Mâle , Études rétrospectives , Hémorragie/étiologie , Hémorragie/diagnostic , Hémorragie/thérapie , Adulte , Maladies des surrénales/diagnostic , Maladies des surrénales/complications , Maladies des surrénales/imagerie diagnostique , Maladies des surrénales/étiologie , Sujet âgé , Surrénalectomie , Glandes surrénales/vascularisation , Glandes surrénales/imagerie diagnostique , Glandes surrénales/anatomopathologie
16.
Hypertens Res ; 47(6): 1719-1727, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38565699

RÉSUMÉ

Recent studies have explored the association between primary aldosteronism and cardiovascular disease incidence. The association between specific primary aldosteronism treatments and differential improvement in cardiovascular event rates is yet to be established. This study was designed to compare the relative effects of spironolactone therapy and surgical intervention on cardiovascular outcomes among primary aldosteronism patients. This retrospective observational study included 853 primary aldosteronism patients from the First Affiliated Hospital of China Medical University between 2014 and 2022. Patients who had completed abdominal computed tomography (CT) examinations with similar metabolic characteristics and 6-month follow-up analyses were included in this study. These patients were separated into a surgical treatment group (n = 33) and a spironolactone treatment group (n = 51). Demographic data, biochemical analysis results, liver/spleen (L/S) X-ray attenuation ratio, hospitalization frequency, and cardiovascular events were compared between the two groups. The spironolactone group demonstrated significantly improved metabolic characteristics compared to the surgical group, shown by lower BMI, blood pressure, total cholesterol (TC), insulin resistance index (IRI), and reduced non-alcoholic fatty liver disease prevalence. Metabolic parameters did not differ significantly within the surgical treatment group when comparing pre- and postoperative values. The incidence of cardiovascular events was lower in the spironolactone group compared to the surgery group (23/33 vs. 20/51, P < 0.001) despite higher hospitalization rates(37/31 vs. 61/53, P < 0.001). In patients with primary aldosteronism, spironolactone treatment is more effective than surgical intervention in remediating abnormal lipid and glucose metabolism while improving cardiovascular outcomes. Chinese clinical trial registry registration number: ChiCTR2300074574.


Sujet(s)
Maladies cardiovasculaires , Hyperaldostéronisme , Spironolactone , Humains , Hyperaldostéronisme/complications , Hyperaldostéronisme/traitement médicamenteux , Hyperaldostéronisme/thérapie , Mâle , Femelle , Adulte d'âge moyen , Études rétrospectives , Adulte , Maladies cardiovasculaires/étiologie , Spironolactone/usage thérapeutique , Glycolipides/métabolisme , Antagonistes des récepteurs des minéralocorticoïdes/usage thérapeutique , Résultat thérapeutique , Surrénalectomie , Chine/épidémiologie
17.
World J Surg ; 48(1): 121-129, 2024 01.
Article de Anglais | MEDLINE | ID: mdl-38651548

RÉSUMÉ

BACKGROUND: We analyze the long-term outcome of surgery for Cushing's syndrome (CS) and the influence of the extent of surgical resection on the duration of postoperative cortisone substitution. METHODS: One-hundred forty-one patients (129 female, 12 males; mean age: 45.7 ± 12.8 years) operated between January 2000 to June 2020 were included in the analysis. Patients suffered from manifest (124) or subclinical (17) CS due to benign unilateral adrenal neoplasia. All tumors were removed by the posterior retroperitoneoscopic approach. 105 patients had total (TA) and 36 partial (PA) adrenalectomies. All patients were discharged with ongoing corticosteroid supplementation therapy. RESULTS: Follow-up data could be obtained for 83 patients. Twenty-four (1 male, 23 females; mean age 42.3 years) underwent PA and 59 TA (6 males, 53 females; mean age 44.6 years). Mean follow-up time was 107 ± 68 months (range: 6-243 months). The median duration of postoperative corticosteroid therapy was 9.5 months after PA and 11 months after TA (p = 0.1). Significantly, more patients after total adrenalectomy required corticosteroid therapy for more than 24 months (25% vs. 4%; p = 0.03). Recurrent ipsilateral disease occurred in one case after partial adrenalectomy and was treated by completion adrenalectomy. A case of contralateral recurrence associated with subclinical Cushing's syndrome was observed after total adrenalectomy. CONCLUSIONS: The risk of local recurrence after partial adrenalectomy in CS is low. Cortical-sparing surgery may shorten corticosteroid supplementation therapy after surgery.


Sujet(s)
Surrénalectomie , Syndrome de Cushing , Humains , Syndrome de Cushing/chirurgie , Femelle , Mâle , Surrénalectomie/méthodes , Adulte d'âge moyen , Adulte , Résultat thérapeutique , Études rétrospectives , Laparoscopie/méthodes , Facteurs temps , Études de suivi , Espace rétropéritonéal/chirurgie
18.
J Am Vet Med Assoc ; 262(7): 1-5, 2024 Jul 01.
Article de Anglais | MEDLINE | ID: mdl-38599229

RÉSUMÉ

OBJECTIVE: To report the survival times in dogs diagnosed with adrenal tumors with vascular or soft tissue invasion that did not undergo adrenalectomy. ANIMALS: Retrospective case series of 32 client-owned dogs. METHODS: The medical records of a referral veterinary hospital were reviewed to identify dogs that were diagnosed with an invasive adrenal mass and did not undergo adrenalectomy between January 2013 and December 2022. Data collected included signalment, examination findings, and diagnostic results from the initial presentation. Descriptive statistics were calculated to summarize dog signalment information, and Kaplan-Meier survival analysis was performed for calculation of median survival time. RESULTS: Most dogs (n = 28) had vascular invasion, primarily into the caudal vena cava. Surgery was offered but not pursued due to perceived risk of sudden death (n = 5), risk of hemorrhage (4), or concurrent diagnosis of disseminated intravascular coagulation (1). Only 1 dog pursued stereotactic body radiation therapy, and 1 was prescribed toceranib phosphate (Palladia). Of these 32 dogs, 30 (93.8%) died or were euthanized and 2 (6.2%) dogs survived. The median follow-up time was 49 days (range, 0 to 1,910 days). The median survival time was 50 days (95% CI, 4 to 194 days). The most common cause of death or euthanasia was hemoabdomen (n = 8). CLINICAL RELEVANCE: Nonsurgical management of invasive adrenal tumors was associated with short survival times in this case series.


Sujet(s)
Tumeurs de la surrénale , Surrénalectomie , Maladies des chiens , Animaux , Chiens , Maladies des chiens/chirurgie , Tumeurs de la surrénale/médecine vétérinaire , Tumeurs de la surrénale/chirurgie , Tumeurs de la surrénale/mortalité , Tumeurs de la surrénale/anatomopathologie , Études rétrospectives , Mâle , Femelle , Surrénalectomie/médecine vétérinaire , Analyse de survie , Invasion tumorale , Résultat thérapeutique
19.
BMC Urol ; 24(1): 90, 2024 Apr 18.
Article de Anglais | MEDLINE | ID: mdl-38637748

RÉSUMÉ

BACKGROUND: Laparoscopic adrenalectomy is widely performed for a number of hormone-producing tumors and postoperative management depends on the hormones produced. In the present study, we conducted a retrospective analysis to clarify the risk factors for postoperative complications, particularly postoperative fever after laparoscopic adrenalectomy. METHODS: We analyzed 406 patients who underwent laparoscopic adrenalectomy at our hospital between 2003 and 2019. Postoperative fever was defined as a fever of 38 °C or higher within 72 h after surgery. We investigated the risk factors for postoperative fever after laparoscopic adrenalectomy. RESULTS: There were 188 males (46%) and 218 females (54%) with a median age of 52 years. Among these patients, tumor pathologies included 188 primary aldosteronism (46%), 75 Cushing syndrome (18%), and 80 pheochromocytoma (20%). Postoperative fever developed in 124 of all patients (31%), 30% of those with primary aldosteronism, 53% of those with pheochromocytoma, and 8% of those with Cushing syndrome. A multivariate logistic regression analysis identified pheochromocytoma and non-Cushing syndrome as independent predictors of postoperative fever. Postoperative fever was observed in 42 out of 80 cases of pheochromocytoma (53%), which was significantly higher than in cases of non-pheochromocytoma (82/326, 25%, p < 0.01). In contrast, postoperative fever developed in 6 out of 75 cases of Cushing syndrome (8%), which was significantly lower than in cases of non-Cushing syndrome (118/331, 35.6%, p < 0.01). CONCLUSION: Since postoperative fever after laparoscopic adrenalectomy is markedly affected by the hormone produced by pheochromocytoma and Cushing syndrome, it is important to carefully consider the need for treatment.


Sujet(s)
Tumeurs de la surrénale , Syndrome de Cushing , Hyperaldostéronisme , Laparoscopie , Phéochromocytome , Mâle , Femelle , Humains , Adulte d'âge moyen , Surrénalectomie/effets indésirables , Syndrome de Cushing/chirurgie , Phéochromocytome/chirurgie , Études rétrospectives , Études cas-témoins , Laparoscopie/effets indésirables , Tumeurs de la surrénale/chirurgie , Tumeurs de la surrénale/anatomopathologie , Facteurs de risque , Hyperaldostéronisme/chirurgie , Hormones
20.
Front Endocrinol (Lausanne) ; 15: 1310408, 2024.
Article de Anglais | MEDLINE | ID: mdl-38645425

RÉSUMÉ

Adrenocortical carcinoma (ACC) is a rare malignancy originating in the adrenal glands, aldosterone-producing ACC, even rarer. Papillary thyroid carcinoma (PTC), by contrast, accounts for the majority of thyroid carcinomas. We herein describe the first reported case of a female with comorbidities of aldosterone-producing ACC, PTC, and Graves' Disease(GD). The patient achieved transient clinical remission following adrenalectomy. However, three months later, aldosterone-producing ACC lung metastases emerged. Subsequently, within another three-month interval, she developed thyroid eye disease(TED). The patient died roughly one year after the adrenal operation. Exome sequencing did not reveal associations between aldosterone-producing ACC, PTC, and GD, and the underlying concurrence mechanism has yet to be elucidated. Further research of similar cases are needed to confirm potential links between the three pathologies.


Sujet(s)
Tumeurs corticosurrénaliennes , Carcinome corticosurrénalien , Aldostérone , Maladie de Basedow , Cancer papillaire de la thyroïde , Tumeurs de la thyroïde , Humains , Femelle , Cancer papillaire de la thyroïde/métabolisme , Cancer papillaire de la thyroïde/anatomopathologie , Cancer papillaire de la thyroïde/génétique , Carcinome corticosurrénalien/métabolisme , Carcinome corticosurrénalien/anatomopathologie , Maladie de Basedow/métabolisme , Maladie de Basedow/complications , Maladie de Basedow/anatomopathologie , Tumeurs de la thyroïde/métabolisme , Tumeurs de la thyroïde/anatomopathologie , Tumeurs corticosurrénaliennes/métabolisme , Tumeurs corticosurrénaliennes/anatomopathologie , Tumeurs corticosurrénaliennes/complications , Aldostérone/métabolisme , Adulte d'âge moyen , Surrénalectomie , Issue fatale
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...